Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPX-RSV(A) Vaccine in Healthy Adults 50-64 Years
NCT02472548Phase 1Completed
- Sponsor
- Dalhousie University
- Start
- May 2015
- Primary completion
- Mar 2017
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DPX-RSV(A) in respiratory syncytial virus infection (RSV), sponsored by Dalhousie University. Started May 2015; status: completed.
02
Drugs
DPX-RSV(A)
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02472548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472548.